Want to join the conversation?
$TMO 2Q15 Call: Laboratory Products and Services segment reported Q2 revenue was flat to prior year and organic growth was 8%. Adjusted operating income increased 1% and adjusted operating margin was 15.4%, up 20 basis points from the prior year.
No better outlook on $MSFT. Even if the results beat a bit, the stock may move 4 to 6% higher, but won't go above $60.